Sivia Capital Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$450K Buy
+1,163
New +$431K 0.05% 372
2026
Q1
Sell
-1,430
Closed -$501K 517
2025
Q4
$501K Buy
1,430
+340
+31% +$115K 0.1% 265
2025
Q3
$352K Buy
+1,090
New +$339K 0.1% 268
2025
Q2
Sell
-902
Closed -$392K 441
2025
Q1
$392K Buy
+902
New +$362K 0.18% 112
2024
Q4
Sell
-552
Closed -$287K 214
2024
Q3
$287K Buy
552
+6
+1% +$3.21K 0.17% 123
2024
Q2
$296K Buy
546
+47
+9% +$24.8K 0.2% 110
2024
Q1
$259K Hold
499
0.18% 135
2023
Q4
$235K Buy
+499
New +$231K 0.18% 137

Other funds holding ELV

Sivia Capital Partners's ELV Position: Q2 2026 in Review

Sivia Capital Partners opened a new position in Elevance Health (ELV) in Q2 2026: 1,163 shares worth $450K. The stake represents 0.05% of the portfolio and ranks #372 among its holdings. This is a return to the name: Sivia Capital Partners previously reported a position in ELV as recently as Q4 2025.

Sivia Capital Partners first reported a position in ELV in Q4 2023 and has held it in 8 quarters since. The position peaked at $501K in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Sivia Capital Partners held 1,163 shares of Elevance Health worth $450K as of Q2 2026.
  • Elevance Health was a new Sivia Capital Partners position in Q2 2026.
  • Elevance Health made up 0.05% of Sivia Capital Partners's portfolio in Q2 2026, its #372 holding.
  • Sivia Capital Partners first reported a position in Elevance Health in Q4 2023 and has held it in 8 quarters since.
  • Sivia Capital Partners's Elevance Health position peaked at $501K in Q4 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.